Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeroen Janssen

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
European Journal of Haematology|November 1, 2015
Chronic myeloid leukemia in the Netherlands: a population-based study on incidence, treatment, and survival in 3585 patients from 1989 to 2012Noortje Thielen, Otto Visser, Gert Ossenkoppele, et al.
BMC Medical Education|January 25, 2023
Inclusion and diversity within medical education: a focus group study of students' experiencesAnne-Roos Verbree, Ulviye Isik, Jeroen Janssen, et al.
Journal of Medical Economics|July 18, 2009
Costs of haematological adverse events in chronic myeloid leukaemia patients: a retrospective cost analysis of the treatment of anaemia, neutropenia and thrombocytopenia in patients with chronic myeloid leukaemiaClazien Bouwmans, Jeroen Janssen, Peter Huijgens, et al.
International Journal of Data Mining and Bioinformatics|May 6, 2011
Modelling gene and protein regulatory networks with answer set programmingTimur Fayruzov, Jeroen Janssen, Dirk Vermeir, et al.
Nederlands Tijdschrift Voor Geneeskunde|May 21, 2015
[Fatal tuberculosis during treatment with ruxolitinib]Sytze Keizer, Roald Gerritsen, Yvonne Jauw, et al.
International Journal of Educational Technology in Higher Education|January 30, 2023
The effectiveness of Collaborative Online International Learning (COIL) on intercultural competence development in higher educationSimone Hackett, Jeroen Janssen, Pamela Beach, et al.
Leukemia|May 6, 2020
Expert opinion-management of chronic myeloid leukemia after resistance to second-generation tyrosine kinase inhibitorsAndreas Hochhaus, Massimo Breccia, Giuseppe Saglio, et al.
JMIR Formative Research|October 20, 2023
A Digital Gaming Intervention to Strengthen the Social Networks of Older Dutch Adults: Mixed Methods Process Evaluation of a Digitally Conducted Randomized Controlled TrialJeroen Janssen, Bas Châtel, Nora Den Heijer, et al.
Journal of Cancer Research and Clinical Oncology|January 14, 2017
No influence of BCR-ABL1 transcript types e13a2 and e14a2 on long-term survival: results in 1494 patients with chronic myeloid leukemia treated with imatinibMarkus Pfirrmann, Dobromira Evtimova, Susanne Saussele, et al.
Nature Communications|May 30, 2013
Drug-induced histone eviction from open chromatin contributes to the chemotherapeutic effects of doxorubicinBaoxu Pang, Xiaohang Qiao, Lennert Janssen, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
European Journal of Haematology|November 1, 2015
Chronic myeloid leukemia in the Netherlands: a population-based study on incidence, treatment, and survival in 3585 patients from 1989 to 2012Noortje Thielen, Otto Visser, Gert Ossenkoppele, et al.
BMC Medical Education|January 25, 2023
Inclusion and diversity within medical education: a focus group study of students' experiencesAnne-Roos Verbree, Ulviye Isik, Jeroen Janssen, et al.
Journal of Medical Economics|July 18, 2009
Costs of haematological adverse events in chronic myeloid leukaemia patients: a retrospective cost analysis of the treatment of anaemia, neutropenia and thrombocytopenia in patients with chronic myeloid leukaemiaClazien Bouwmans, Jeroen Janssen, Peter Huijgens, et al.
International Journal of Data Mining and Bioinformatics|May 6, 2011
Modelling gene and protein regulatory networks with answer set programmingTimur Fayruzov, Jeroen Janssen, Dirk Vermeir, et al.
Nederlands Tijdschrift Voor Geneeskunde|May 21, 2015
[Fatal tuberculosis during treatment with ruxolitinib]Sytze Keizer, Roald Gerritsen, Yvonne Jauw, et al.
International Journal of Educational Technology in Higher Education|January 30, 2023
The effectiveness of Collaborative Online International Learning (COIL) on intercultural competence development in higher educationSimone Hackett, Jeroen Janssen, Pamela Beach, et al.
Leukemia|May 6, 2020
Expert opinion-management of chronic myeloid leukemia after resistance to second-generation tyrosine kinase inhibitorsAndreas Hochhaus, Massimo Breccia, Giuseppe Saglio, et al.
JMIR Formative Research|October 20, 2023
A Digital Gaming Intervention to Strengthen the Social Networks of Older Dutch Adults: Mixed Methods Process Evaluation of a Digitally Conducted Randomized Controlled TrialJeroen Janssen, Bas Châtel, Nora Den Heijer, et al.
Journal of Cancer Research and Clinical Oncology|January 14, 2017
No influence of BCR-ABL1 transcript types e13a2 and e14a2 on long-term survival: results in 1494 patients with chronic myeloid leukemia treated with imatinibMarkus Pfirrmann, Dobromira Evtimova, Susanne Saussele, et al.
Nature Communications|May 30, 2013
Drug-induced histone eviction from open chromatin contributes to the chemotherapeutic effects of doxorubicinBaoxu Pang, Xiaohang Qiao, Lennert Janssen, et al.
Pageof 3